These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6401848)

  • 1. Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH; Sawchuk RJ; Eggerth RM
    Neurology; 1983 Feb; 33(2):185-91. PubMed ID: 6401848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.
    Chiba K; Suganuma T; Ishizaki T; Iriki T; Shirai Y; Naitoh H; Hori M
    J Pediatr; 1985 Apr; 106(4):653-8. PubMed ID: 3920375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics?
    Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P
    Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-dose and steady-state pharmacokinetics of valproic acid in children with seizures.
    Hall K; Otten N; Irvine-Meek J; Leroux M; Budnick D; Verma M; Seshia SS
    Clin Pharmacokinet; 1983; 8(5):447-55. PubMed ID: 6414752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid pharmacokinetics in children. II. Discontinuation of concomitant antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH
    Neurology; 1985 Nov; 35(11):1623-7. PubMed ID: 3932898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid dosages necessary to maintain therapeutic concentrations in children.
    Suzuki Y; Cox S; Hayes J; Walson PD
    Ther Drug Monit; 1991 Jul; 13(4):314-7. PubMed ID: 1780963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid pharmacokinetics in children: III. Very high dosage requirements.
    Kriel RL; Fischer JH; Cloyd JC; Green KH; Fraser GL
    Pediatr Neurol; 1986; 2(4):202-8. PubMed ID: 3150281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy.
    Hoffmann F; von Unruh GE; Jancik BC
    Eur J Clin Pharmacol; 1981; 19(5):383-5. PubMed ID: 6786896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
    Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
    Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of rectally administered valproic acid syrup.
    Cloyd JC; Kriel RL
    Neurology; 1981 Oct; 31(10):1348-52. PubMed ID: 6810203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus.
    Hovinga CA; Chicella MF; Rose DF; Eades SK; Dalton JT; Phelps SJ
    Ann Pharmacother; 1999 May; 33(5):579-84. PubMed ID: 10369622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
    Van Matre ET; Cook AM
    Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multivariable analysis of factors governing the steady-state pharmacokinetics of valproic acid in 52 young epileptics.
    Hall K; Otten N; Johnston B; Irvine-Meek J; Leroux M; Seshia S
    J Clin Pharmacol; 1985; 25(4):261-8. PubMed ID: 3924980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.